INTRODUCTION
If you are looking to bring a brand-new medical device into India one that doesn’t have a “predicate” (a similar device already on the market) you might feel like you’ve entered a maze of forms and acronyms. You have probably heard of Form MD-26 and Form MD-27, but did you know there is often a critical “Boss Battle” in between them called the SEC Meeting?
WHAT IS FORM MD-26 AND MD-27?
Think of these two forms as the “Ask” and the “Answer.”
- Form MD-26 (The Application): This is the form you submit to the Central Licensing Authority (CLA) to ask for permission to import or manufacture a medical device that does not yet have a predicate in India (often called an “Investigational Medical Device”).
- Form MD-27 (The Permission): This is the “Golden Ticket.” It is the official permission granted by the Central Drugs Standard Control Organization if your application is successful. It allows you to import or manufacture the device for sale or distribution.
THE "HIDDEN" STEP: THE SUBJECT EXPERT COMMITTEE (SEC)
Here is the part most blogs don’t tell you. Between submitting MD-26 and getting MD-27, your application is often reviewed by a Subject Expert Committee (SEC).
The SEC is a panel of 8 experts (doctors, pharmacologists, and specialists) who advise the Drug Controller General of India (DCGI) on whether your device is safe and effective.
HOW TO WIN THE SEC PRESENTATION
According to the CDSCO SEC Guidelines (Ver. 1.0-2025) you uploaded, you can’t just walk in and wing it. You must follow these strict presentation rules:
- The 20-Slide Rule: Your presentation is restricted to roughly 20-25 slides. Do not bring a 100-page deck!.
- The “Rule of Six”: To keep things readable, use a maximum of 6 lines per slide and 6 words per line.
- Font Discipline: Use professional fonts like Arial or Calibri. Titles must be 36 pt, headings 30 pt, and body text 20 pt.
- Advance Warning: You will only receive the meeting notice 5 days in advance, so your materials need to be ready before you get the call.
THE "CHEAT CODES": CLINICAL TRIAL WAIVERS
One of the biggest hurdles for new devices is the requirement for local clinical trials. However, the guidelines reveal a potential shortcut.
You may request a Waiver of Local Clinical Trials if:
- Your device is already approved in “GHTF Countries” (USA, UK, Japan, Australia, Canada, or the EU).
- You can prove there is no theoretical possibility of a difference in the device’s behavior or performance in the Indian population.
Pro Tip: If you want this waiver, you must explicitly justify it in your presentation with data, don’t just hope they give it to you.
WHO CAN APPLY FOR MD-26 AND MD-27?
Based on the checklist and guidelines, the following entities can apply:
- Importers: Those holding a valid wholesale license who want to bring a new device into India.
- Domestic Manufacturers: Indian companies who want to manufacture a Class A, B, C, or D device that has no predicate in India.
- Authorized Agents: If you are a foreign manufacturer, your authorized agent in India can apply on your behalf.
WHAT ARE THE DOCUMENTS REQUIRED? (THE CHECKLIST)
Submitting Form MD-26 isn’t just about filling out a form. According to the Form MD-26 Checklist, you must submit a “dossier” of technical documents.
The Mandatory “Must-Haves”:
- Cover Letter: The basics.
- Justification for Classification: Why is your device Class A, B, C, or D?.
- Regulatory Status: Notarized copies of approvals from the US, UK, Canada, Japan, Australia, etc. (Crucial for waivers!).
- Design Analysis Data: Input/output documents, validation reports, and software verification.
- Risk Management Report: A detailed report on the risks associated with your device.
- Biocompatibility Studies: Data proving the materials are safe for human contact.
- Animal Performance Data: If applicable, you need studies showing how it performed in animal models.
- Post-Marketing Surveillance (PMS) Data: If you have sold the device in other countries for over 2 years, you must provide safety data from those markets.
CONCLUSION
Form MD-26 and MD-27 are essential for any manufacturer looking to introduce a new or investigational medical device into India. Understanding the process, assembling a compliant application, and preparing for SEC review are key steps toward approval. By aligning with the latest guidance and preparing thoroughly, manufacturers can navigate India’s regulatory landscape confidently ensuring that their devices reach patients safely, ethically, and efficiently.
HOW MORULAA CAN HELP
Form MD-26 and MD-27 are essential for any manufacturer looking to introduce a new or investigational medical device into India. Understanding the process, assembling a compliant application, and preparing for SEC review are key steps toward approval. By aligning with the latest guidance and preparing thoroughly, manufacturers can navigate India’s regulatory landscape confidently ensuring that their devices reach patients safely, ethically, and efficiently.